Your browser doesn't support javascript.
loading
Effects of hydroxychloroquine on symptomatic improvement in primary Sjögren syndrome: the JOQUER randomized clinical trial.
Gottenberg, Jacques-Eric; Ravaud, Philippe; Puéchal, Xavier; Le Guern, Véronique; Sibilia, Jean; Goeb, Vincent; Larroche, Claire; Dubost, Jean-Jacques; Rist, Stéphanie; Saraux, Alain; Devauchelle-Pensec, Valérie; Morel, Jacques; Hayem, Gilles; Hatron, Pierre; Perdriger, Aleth; Sene, Damien; Zarnitsky, Charles; Batouche, Djilali; Furlan, Valérie; Benessiano, Joelle; Perrodeau, Elodie; Seror, Raphaele; Mariette, Xavier.
Afiliação
  • Gottenberg JE; Department of Rheumatology, Service de Rhumatologie, Hôpitaux Universitaires de Strasbourg, Centre de Référence National Pour les Maladies Auto-Immunes Systémiques Rares, Université de Strasbourg, Strasbourg, France.
  • Ravaud P; Department of Epidemiology and Public Health, Hotel Dieu, Assistance Publique-Hôpitaux de Paris (AP-HP), Paris, France.
  • Puéchal X; Department of Internal Medicine, Cochin Hospital, AP-HP, Paris, France.
  • Le Guern V; Department of Internal Medicine, Cochin Hospital, AP-HP, Paris, France.
  • Sibilia J; Department of Rheumatology, Service de Rhumatologie, Hôpitaux Universitaires de Strasbourg, Centre de Référence National Pour les Maladies Auto-Immunes Systémiques Rares, Université de Strasbourg, Strasbourg, France.
  • Goeb V; Department of Rheumatology, Amiens University Hospital, Amiens, France.
  • Larroche C; Department of Internal Medicine, Avicenne Hospital, AP-HP, Bobigny, France.
  • Dubost JJ; Department of Rheumatology, Clermont-Ferrand University Hospital, Clermont-Ferrand, France.
  • Rist S; Department of Rheumatology, Orléans Hospital, Orléans, France.
  • Saraux A; Department of Rheumatology, Brest University Hospital, Brest, France.
  • Devauchelle-Pensec V; Department of Rheumatology, Brest University Hospital, Brest, France.
  • Morel J; Department of Rheumatology, Montpellier University Hospital, Montpellier, France.
  • Hayem G; Department of Rheumatology, Hôpital Bichat, AP-HP, Paris, France.
  • Hatron P; Department of Internal Medicine, Lille University Hospital, Lille, France.
  • Perdriger A; Department of Rheumatology, Rennes University Hospital, Rennes, France.
  • Sene D; Department of Internal Medicine, Lariboisère Hospital, AP-HP, Paris, France.
  • Zarnitsky C; Department of Rheumatology, Le Havre Hospital, Le Havre, France.
  • Batouche D; Department of Rheumatology, Hôpitaux Universitaires Paris-Sud, AP-HP, INSERM U 1012, Université Paris Sud, Le Kremlin Bicêtre, France.
  • Furlan V; Department of Pharmacy, Hôpitaux Universitaires Paris-Sud, AP-HP, Le Kremlin Bicêtre, France.
  • Benessiano J; Department of Centre de Ressources Biologiques, Bichat Hospital, AP-HP, Paris, France.
  • Perrodeau E; Department of Epidemiology and Public Health, Hotel Dieu, Assistance Publique-Hôpitaux de Paris (AP-HP), Paris, France.
  • Seror R; Department of Rheumatology, Hôpitaux Universitaires Paris-Sud, AP-HP, INSERM U 1012, Université Paris Sud, Le Kremlin Bicêtre, France.
  • Mariette X; Department of Rheumatology, Hôpitaux Universitaires Paris-Sud, AP-HP, INSERM U 1012, Université Paris Sud, Le Kremlin Bicêtre, France.
JAMA ; 312(3): 249-58, 2014 Jul 16.
Article em En | MEDLINE | ID: mdl-25027140

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Síndrome de Sjogren / Inibidores Enzimáticos / Hidroxicloroquina Tipo de estudo: Clinical_trials / Diagnostic_studies / Etiology_studies / Prognostic_studies Limite: Adult / Aged / Female / Humans / Male / Middle aged Idioma: En Ano de publicação: 2014 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Síndrome de Sjogren / Inibidores Enzimáticos / Hidroxicloroquina Tipo de estudo: Clinical_trials / Diagnostic_studies / Etiology_studies / Prognostic_studies Limite: Adult / Aged / Female / Humans / Male / Middle aged Idioma: En Ano de publicação: 2014 Tipo de documento: Article